Loading organizations...
Biotechnology company developing targeted protein degradation technology.
Ranok Therapeutics has raised $40.0M across 1 funding round.
Ranok Therapeutics has raised $40.0M in total across 1 funding round.
Ranok Therapeutics has raised $40.0M in total across 1 funding round.
Ranok Therapeutics's investors include Zhihua Yu, Hong Wen, Wu Capital, Zhongguancun Kaiyuan Capital.
Ranok Therapeutics has raised $40.0M across 1 funding round. Most recently, it raised $40.0M Series B in August 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 18, 2021 | $40.0M Series B | Zhihua Yu, Hong Wen | Wu Capital, Zhongguancun Kaiyuan Capital |